New Jersey Senate Bill S1077

New Jersey 2022-2023 Regular Session

• Introduced: 1/31/22
• Refer: 1/31/22

Caption

Requires pharmacies to sell hypodermic syringes and needles to any customer over the age of 18 and post sign concerning consumer right to purchase clean syringes and needles.

Impact

The passage of S1077 would amend existing statutes relating to pharmacy sales of hypodermic syringes as established in 2011 under P.L.2011, c.183, which was originally aimed at enhancing public health through access to clean syringes. By streamlining the purchasing process and making it mandatory for pharmacies to sell these items, the bill is positioned to curb the spread of bloodborne diseases like HIV and hepatitis C. Furthermore, pharmacists will be required to provide information related to safe syringe disposal and substance abuse treatment options at the point of sale, ensuring that education accompanies accessibility.

Summary

Senate Bill S1077 introduces a mandate for pharmacies in New Jersey to sell hypodermic syringes and needles to any customer aged 18 and above. This legislative change transitions the existing optional framework into a requirement, thereby increasing access to these medical supplies. Under current laws, syringes could be sold without a prescription in limited quantities, while larger quantities required a prescription. With S1077, pharmacies are now compelled to offer these items, broadening access for various users, including those with medical needs and individuals requiring them for substance use management.

Contention

While the intent of S1077 is to further public health goals, it may also invoke discussions regarding the responsibilities of pharmacies and the implications of facilitating syringe access. Notably, there may be concerns among certain community members about addiction and the potential for misuse of syringes. Additionally, pharmacies will need to balance compliance with new operational mandates while addressing public health implications. The mandated signage at pharmacies informing customers of their rights to purchase syringes will also contribute to the integration of public health messaging into routine pharmacy operations.